Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
S Jagasia, E Tasci, Ying Zhuge, K Camphausen & AV Krauze. (2023) Identifying patients suitable for targeted adjuvant therapy: advances in the field of developing biomarkers for tumor recurrence following irradiation. Expert Review of Precision Medicine and Drug Development 8:1, pages 33-42.
Read now
Read now
Articles from other publishers (4)
Lizhen Zhang, Siyu Li, Desheng Zhang, Chun Yin, Zhongge Wang, Ruirui Chen, Ning Cheng & Yana Bai. (2024) Value of GPR, APPRI and FIB-4 in the early diagnosis of hepatocellular carcinoma: a prospective cohort study. Japanese Journal of Clinical Oncology 54:2, pages 129-136.
Crossref
Crossref
Shangdong Mu, Qingjuan Chen, Shuo Li, Dongfeng Wang, Yongchang Zhao, Xiang Li, Wei Fu, Zhigang Fan, Shan Tian & Zeng Li. (2023) Incomplete radiofrequency ablation following transarterial chemoembolization accelerates the progression of large hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 19:4, pages 924-932.
Crossref
Crossref
Xinyuan Zhang, Yujing Xin, Yi Chen & Xiang Zhou. (2023) Prognostic effect of albumin-to-alkaline phosphatase ratio on patients with hepatocellular carcinoma: a systematic review and meta-analysis. Scientific Reports 13:1.
Crossref
Crossref
Lei Xu, Lin Chen, Bin Zhang, Zhicheng Liu, Qiumeng Liu, Huifang Liang, Yifa Chen, Xiaoping Chen, Chao Leng & Bixiang Zhang. (2023) Alkaline phosphatase combined with γ-glutamyl transferase is an independent predictor of prognosis of hepatocellular carcinoma patients receiving programmed death-1 inhibitors. Frontiers in Immunology 14.
Crossref
Crossref